ArticleThe Biochemical journal2026
Influence of SmpB and ClpX interactions and interactomes on the transcription profile of Mycobacterium tuberculosis.
Article in The Biochemical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Small protein B (SmpB) is a key regulator of trans-translation in bacteria. The interactome of Mycobacterium tuberculosis (Mtb) ClpX revealed SmpB alongside multiple transcriptional regulators and σ factors that can alter the transcriptional profile. The finding that ClpX could also be identified in the Mtb SmpB interactome suggested both physical and functional linkages between trans-translation and targeted protein degradation. The trans-translation mechanism facilitates the release of stalled ribosomes and the attachment of ssrA degron sequences to aberrant proteins. We show that both SmpB and the previously described Mtb ClpX adaptor, single-stranded DNA binding protein (SSB), bind to the N-terminal domain of ClpX. However, unlike the adaptor SSB, SmpB binding does not enhance ClpX ATPase activity. Interaction studies using a model substrate with an exposed ssrA degron revealed that SmpB enhances ClpX-substrate interactions. ClpX unfoldase activity, on the other hand, enables targeted degradation of proteins containing the ssrA degron. ClpX also facilitates the release of specific σ factors from inactive σ/anti-σ complexes by degrading anti-σ factors containing the ssrA degron, thus indirectly influencing the transcription profile. Together, these observations suggest that SmpB and ClpX interactions and interacting protein networks exert both direct and indirect effects on the Mtb transcriptional profile.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.